BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Bangkok
BEGIN:STANDARD
TZOFFSETFROM:+0700
TZOFFSETTO:+0700
TZNAME:+07
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20180311T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20181104T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20190310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20191103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20200308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20201101T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190909
DTEND;VALUE=DATE:20190910
DTSTAMP:20190812T140040Z
CREATED:20190812T140040Z
LAST-MODIFIED:20190812T140040Z
UID:29961-1567987200-1568073599@globalbiodefense.com
SUMMARY:Comments Due:  2019 Draft Guidelines for the Prevention\, Diagnosis\, and Treatment of Lyme Disease
DESCRIPTION:The Infectious Diseases Society of America (IDSA)\, American Academy of Neurology (AAN)\, and American College of Rheumatology (ACR) are now accepting comments on the “2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease.” Feedback is sought not only from physicians and healthcare professionals\, but also individuals affected by Lyme disease\, such as patients\, care givers\, patient organization members\, advocates\, and researchers. The deadline for submitting comments has been extended until Sept. 9\, 2019. \nTo view the draft guidelines\, supplementary materials\, and submit comments\, please see below. \n2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease \n2019 Draft Supplement Materials for the Prevention\, Diagnosis and Treatment of Lyme Disease \nPublic comments are due by 5PM Eastern on 9 September 2019.
URL:https://globalbiodefense.com/event/comments-due-2019-draft-guidelines-for-the-prevention-diagnosis-and-treatment-of-lyme-disease/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190909T000000
DTEND;TZID=America/Los_Angeles:20190910T235959
DTSTAMP:20190803T172114Z
CREATED:20181223T184820Z
LAST-MODIFIED:20190803T172114Z
UID:18738-1567987200-1568159999@globalbiodefense.com
SUMMARY:Diagnostic Microbiology and Infectious Diseases Summit
DESCRIPTION:The Diagnostic Microbiology and Infectious Diseases Summit will be held 9-10 September 2019 in Dubai\, UAE. \n\n\n\nThis event provides a pivotal platform to explore outstanding strategies in Diagnostic Microbiology and Infectious Diseases. \n\n\n\nHighlighted topic sessions include: \n\n\n\nResistance and mechanisms of action of antifungalsImmunology of infectious diseasesClinical microbiologyEpidemiology of infectious diseases and public health concernsMedical and clinical case reportsDiagnostic and laboratory methodsInfection control and prevention\n\n\n\nFor additional details and registration\, please visit the Diagnostic Microbiology and Infectious Diseases Summit website.
URL:https://globalbiodefense.com/event/diagnostic-microbiology-and-infectious-diseases-summit/
LOCATION:Dubai\, UAE\, Dubai\, UAE
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/a69947efc015b3366f376f6b134bcc28.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190911
DTEND;VALUE=DATE:20190913
DTSTAMP:20190817T225348Z
CREATED:20190817T224214Z
LAST-MODIFIED:20190817T225348Z
UID:30036-1568160000-1568332799@globalbiodefense.com
SUMMARY:2019 FDA Science Forum
DESCRIPTION:The 2019 FDA Science Forum will be held on 11-12 September 2019 in Silver Spring\, Md. The event may be attended in-person or via Webcast (pre-registration is required). \nFDA’s Science Forum welcomes the public\, industry\, academia\, patient advocates\, sister agencies\, and current and potential collaborator to learn how FDA’s researchers are using novel science and technologies to inform FDA’s regulatory decision-making—and drive innovation. \nAgenda items of interest highlighted by the Global Biodefense staff include: \n\nEmerging & Pandemic Threat Preparedness\nBio-Terrorism Regulations and Food Security\nFDA Food Defense Efforts – A Preventive Approach to Food Terrorism\nCBER-Regulated Products: Preventing and Mitigating Shortages\nViolent Non-State Actor Use of Food as a Delivery System: Comparing ideological and Non-Ideological Perpetrators\nProduct Availability: A Drug Shortage Perspective\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nAvian Influenza A Susceptibilities to Pulmonary Surfactant Protein D: Confirmation of N-glycan sub-type as a Pathogenic Factor in Influenza\nImmune Responses to Zika Infections\nInnovation in Science: Protecting People from Emerging Infectious Disease Threats\nFoodborne Outbreak Investigations in the Whole Genome Sequencing Era\nTracking antibiotic resistance in Salmonella: The role of the National Antimicrobial Resistance Monitoring System\nDeep Learning for Polypharmacy and Drug Repurposing\nC. elegans for Rapid Developmental Neurotoxicity Assessment of Mixtures\nCardiac and Hepatic Cellular Systems to Model Human Drug Effects\nThe VICTRE Project: The First All-In-Silico Imaging Clinical Trial\nDigital Biomarkers Discovery from Patient-Generated Health Data\nAI at FDA: Potential Utility and Regulatory Challenges\nAdvancing Digital Health and Artificial Intelligence\nImpacting Public Health Through Electronic Media: Empowering Consumers\, Patients\, and Other Stakeholders\nMetagenomeTrakr Pilot Program for Rapid Foodborne Pathogen Detection\nPreclinical pharmacology of novel synthetic opioids appearing in clandestine drug markets\nAssessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using PHASE\nAccelerating Innovation in Manufacturing Technology for Biomanufactured Products: Manufacturing U.S. and NIST\nOn the ‘Cyber-Securability’ of Medical Devices\n\nPlease visit the FDA Science Forum website to view the full agenda and register.
URL:https://globalbiodefense.com/event/2019-fda-science-forum/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/08/2019-fda-science-forum.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20190911T000000
DTEND;TZID=America/Los_Angeles:20190913T235959
DTSTAMP:20190803T220610Z
CREATED:20190621T165248Z
LAST-MODIFIED:20190803T220610Z
UID:29339-1568160000-1568419199@globalbiodefense.com
SUMMARY:Legionella Conference 2019
DESCRIPTION:The Legionella Conference 2019\, hosted by NSF International and the National Environmental Health Association\, will be held 11-13 September 2019 in Los Angeles\, California. \n\n\n\nAn international lineup of public health and sustainability experts from four continents will discuss complex hospital water systems\, cooling towers\, proactive water quality monitoring and other topics at the conference. \n\n\n\nThe 2019 Legionella Conference theme\, “Building Water Systems: The Sustainability and Public Health Nexus\,” centers on how both industries can help align water and energy sustainability and public health goals. \n\n\n\nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\n\n\nHow Public Health Officials Can Make Defensible Decisions With Limited Data During an OutbreakBuilding the Capacity to Lead Investigations: Finding the Best ResponseWater Conservation Goals and Public Health – Responding to Unintended ConsequencesA Novel Water Heating System for Pathogen ControlWhole-Genome Sequencing and Comparative Genome Analysis: A Pangenome Approach to Understand Population Diversity\, Antimicrobial Resistance\, and Adaptive Mechanisms of Bacterial Pathogens Within the Water System of Large Occupational BuildingsPlace of Point of Use Filters in a Multifaceted Strategy Against Waterborne HAIS in Hospital SettingsNew Open-Cell Foam Sampling Methods for Legionella to Mitigate Risks of False Non-DetectsThe Basis for Criminal and Civil Liability for Public Health Officials in State Public Health Law and Ethical Perspective on Risk Communication During OutbreaksSummary of Performance of Legiolert™ Vs. Standard Methods for the Quantification of Legionella pneumophila in Non-Potable Water SamplesImproved Management of Legionella Risks Using Rapid On-Site Testing\n\n\n\nLearn more and register at the Legionella Conference 2019 website.
URL:https://globalbiodefense.com/event/legionella-conference-2019/
LOCATION:Westin Bonaventure Hotel and Suites\, 404 S Figueroa St\, Los Angeles\, California\, 90071\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190911T090000
DTEND;TZID=America/New_York:20190911T170000
DTSTAMP:20190906T150226Z
CREATED:20190906T144340Z
LAST-MODIFIED:20190906T150226Z
UID:30253-1568192400-1568221200@globalbiodefense.com
SUMMARY:National Biodefense Science Board: Public Meeting
DESCRIPTION:The HHS Office of the Secretary is hosting the National Biodefense Science Board (NBSB) Public Meeting in Washington\, DC\, on September 11\, 2019. The meeting is also available for remote participation by teleconference. \nThe purpose of the meeting is to gather information to develop expert advice provided by NBSB and guidance to the Secretary on scientific\, technical\, and other matters of special interest to HHS regarding current and future chemical\, biological\, nuclear\, and radiological (CBRN) agents\, whether naturally occurring\, accidental\, or deliberate. \nAgenda items include: \n\nPresentation from the Disaster Medicine Working Group (DMWG)\nExploring Issues in Biodefense Science: Development and Use of Animal Models to Enhance Rapid Approval of Novel MCM\nASPR Program Update: Vision for the Pediatric Disaster Care Centers of Excellence Cooperative Agreement\n\nTeleconference Information:\nToll Numbers (International Callers): 773-799-3992\nToll Free Number: 888-417-0384\nParticipant passcode: 3609874 (Listen only; Public callers\, use for the public NBSB phe.gov site) \nFor further information contact: CAPT Christopher Perdue\, MD\, MPH\, Designated Federal Official\, NBSB\, ASPR\, HHS; 202-401-5837; christopher.perdue@hhs.gov
URL:https://globalbiodefense.com/event/national-biodefense-science-board-public-meeting/
LOCATION:O’Neil Building\, 200 C Street SW\, Washington\, DC\, 20515
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/09/national-biodefense-science-board.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190913
DTEND;VALUE=DATE:20190914
DTSTAMP:20190904T174022Z
CREATED:20190821T041439Z
LAST-MODIFIED:20190904T174022Z
UID:30062-1568332800-1568419199@globalbiodefense.com
SUMMARY:Lightning Talks Application Deadline - BARDA Industry Day Presentations
DESCRIPTION:Submit your application to participate in the BARDA Industry Day 2019 Lightning Talks on 16 Oct 2019. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nApplications will be evaluated on the following criteria: \n\nRelevance to ASPR\, BARDA \, and DRIVe mission\nRelevance to BARDA Industry Day 2019 theme\, “Catalyzing Health Security”\nGoals of proposed talk: Are you seeking partnerships/collaborations? Accelerating product development? Looking for new applications for existing technologies?\n\nApplications must be received by 11:59 PM ET Friday\, September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. \nSubmit Your Application to Present Here: Lightning Talks Submission Form
URL:https://globalbiodefense.com/event/lightning-talk-application-deadline-barda-industry-day-presentations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190915
DTEND;VALUE=DATE:20190919
DTSTAMP:20190812T154325Z
CREATED:20190812T154236Z
LAST-MODIFIED:20190812T154325Z
UID:29971-1568505600-1568851199@globalbiodefense.com
SUMMARY:13th Vaccine Congress
DESCRIPTION:Organizers from Elsevier’s journal Vaccine will host the 13th Vaccine Congress 15-18 September 2019 in Bangkok\, Thailand. \nThe congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field. \nAgenda topics of interest highlighted by the Global Biodefense staff include: \n\nInsertion-responsive microneedles for rapid intradermal delivery of influenza vaccine\nImmunogenicity of virus-like particle (VLP)-based coronavirus vaccines\nA brief review of adversomics: understanding genetic drivers for adverse events after vaccination\nDeveloping a novel\, safe and effective platform for generating flavivirus vaccines\nNovel adenoviral vector platform for developing a universal influenza vaccine\nChicken IFITM knockout technology for increased vaccine production\nThe role of the microbiome in host interactions and vaccine responses\nOptimized recombinant Newcastle disease virus expressing the F protein of respiratory syncytial virus has improved antigen expression levels and immunogenicity\nIdentification of immunostimulatory domains of flagellin for better adjuvant design\nReprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology\nDevelopment of bat stem cell lines by somatic reprogramming to study bat-derived\nhighly pathogenic viruses\nVaccination with 1/6th standard dose of a split inactivated influenza vaccine using the Nanopatch™\ninduces comparable immune responses to conventional full-dose intramuscular injection\nMucosal immunity in therapeutic and prophylactic vaccine trials\nTranslating the intestinal microbiome for oral vaccine performance\nNeuraminidase-based influenza virus vaccines\nAssessment of outer membrane vesicles derived from Escherichia coli Nissle 1917as a novel mucosal adjuvant in intranasal inactivated influenza vaccine\nEnhancing Chikungunya Virus Immunity By Improved Vaccination\nPre-clinical protective efficacy of a VLP-based vaccine against Zika virus\nNeedle Adapters and Needle-free Injectors for Intradermal Administration of Fractional Dose of\nInactivated Poliovirus Vaccine\n\nPlease visit the 13th Vaccine Congress website for more information and to register for the event.
URL:https://globalbiodefense.com/event/13th-vaccine-congress/
LOCATION:Avani Riverside Hotel\, 257 Charoennakorn Road\, Thonburi\, Bangkok\, 10600\, Thailand
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20190924T080000
DTEND;TZID=America/Denver:20190925T170000
DTSTAMP:20190906T132235Z
CREATED:20190906T132235Z
LAST-MODIFIED:20190906T132235Z
UID:30250-1569312000-1569430800@globalbiodefense.com
SUMMARY:Medical Countermeasures Point of Distribution (POD)
DESCRIPTION:The National Center of Excellence At Texas A&M (TEEX) will be delivering their two day course on Point of Distribution (POD) Medical Countermeasures on Sept 24 and 25. \nThis a rare training opportunity as the course is being taught in Western Montana and being offered at no cost! \nClass size is limited\, register quickly!
URL:https://globalbiodefense.com/event/medical-countermeasures-point-of-distribution-pod/
LOCATION:Salish Kootenai College\, 58138 U.S. 93\, Pablo\, MT\, 59855\, United States
CATEGORIES:Conference,Training
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/09/df7e419f5f73e5fb3e28da32e23bd8c1.jpg
END:VEVENT
END:VCALENDAR